menu
Molecular Cytogenetics Market To Reach US$ 11,129.1 Million By 2027
Molecular Cytogenetics Market To Reach US$ 11,129.1 Million By 2027
Molecular Cytogenetics Market Report- 2026 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

Cytogenetics techniques are changing from black and white tocolor. Traditional black and white techniques were associated with thedifficulty of resolution and accuracy that were overcome with the introductionof FISH and aCGH. Molecular cytogenetic techniques such as FISH and aCGH areused for identifying complex chromosomal rearrangements.

Statistics:

The global MolecularCytogenetics Market is estimated to account for US$ 1,970.8 Mn in terms ofvalue by the end of 2019.

Global Molecular Cytogenetics Market: Drivers

Approval and launch of new products is expected to propelgrowth of the global molecular cytogenetics market over the forecast period.For instance, in January 2019, Applied Spectral Imaging launched updatedproducts portfolio that included a new imaging methodology that is based on anall-new algorithm coupled with advanced hardware components to increase thescanning speed for fluorescence in situ hybridization (FISH) imaging.

Global Molecular Cytogenetics Market: Opportunities

Advent in Next Generation Sequencing (NGS) is expected tooffer lucrative growth opportunities for players in the global molecularcytogenetics market. For instance, in October 2019, Illumina, Inc. partneredwith QIAGEN N.V. to broaden the availability and use of NGS-based in-vitrodiagnostic kits, including companion diagnostics, for patient management. 

* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.

Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2491

Global Molecular CytogeneticsMarket: Restraints

Low adoption of molecularcytogenetics in emerging economies is expected to hinder growth of globalmolecular cytogenetics market.

Key Takeaways:

The global molecular cytogeneticsmarket was valued at US$ 1,970.8 Mn in 2019 and is forecast to reach a value ofUS$ 11,129.1 Mn by 2027 at a CAGR of 24.2% between 2020 and 2027. Approval andlaunch of new products is expected to propel growth of the global molecularcytogenetics market over the forecast period.

aCGH segment held dominantposition in the global molecular cytogenetics market in 2019, accounting for64.0% share in terms of value, increasing prevalence of cancer is expected topropel the segment growth during the forecast period.

Market Trends

High prevalence of geneticdisorders is expected to propel growth of the global molecular cytogenetics market.For instance, according to Summary of the Cystic Fibrosis Foundation PatientRegistry, 2003–2018, the number of people with cystic fibrosis increased from21,421 in 2003 to 30,775 in 2018.

Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/molecular-cytogenetics-market-2491

Major players in the globalmolecular cytogenetics market are focused on adopting partnership strategies toenhance their market share. For instance, in April 2018, Precipio, Inc., aspecialty diagnostics company, announced that the company is in activelicensing discussions with several potential partners regarding IV-Cell,Precipio’s proprietary cytogenetics media.

Global Molecular CytogeneticsMarket: Competitive Landscape 

Major players operating in theglobal molecular cytogenetics market include, Abbott Laboratories, Affymetrix,Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI BiologicalIndustries, Bio-Rad Laboratories, CytoTest Inc., Cytognomix, Inc., F.Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc.,and Leica Biosystems.

Global Molecular CytogeneticsMarket: Key Developments

Major players in the globalmolecular cytogenetics market are focused on launching new products to expandtheir product portfolio. For instance, in March 2019, Bionano Genomics, Inc.launched multiple new products and advancements for its Saphyr workflow thatmassively improve throughput, significantly speed up sample prep and allow forthe detection of low-allele frequency structural variants at the 2019 Advancesin Genome Biology and Technology (AGBT) meeting.

Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2491.

AboutCoherent Market Insights:            

CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.

ContactUs:

mailto:sales@coherentmarketinsights.com

U.S.Office:

Name:  Mr. Shah

CoherentMarket Insights 1001 4th Ave,

# 3200Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737